It's likely to be substantial contributor, but it doesn't explain the first peak. Srr figure 3E4 for DecodeME onset ages, infectious and nucleosis, other infections and non-infectious also show a an early onset spike.
And the equivalent for the EMEA data in the supplementary (no glandular fever):Thanks, here's the graph:
View attachment 31313

On what is the based?Spain has drastically fewer glandular fever cases than the UK
On what is the based?
On what is the based?
We cite NICE for uk and Merico-Coy et al 2020 for spain. Statista also provides an estimate here but we struggled to source it https://www.statista.com/statistics...ctious-mononucleosis-among-patients-in-spain/.Furthermore, while the incidence of glandular fever/infectious mononucleosis is 5 per
1,000 in the UK (44), it is an order of magnitude smaller (0.4 per 1,000) in Spain
(45), which in our dataset had the smallest early onset peak.

Does it mean that the risk of getting ME/CFS decreases once you reach that age?